ISSN 1006-298X      CN 32-1425/R

Chinese Journal of Nephrology, Dialysis & Transplantation ›› 2018, Vol. 27 ›› Issue (2): 113-118.DOI: 10.3969/cndt.j.issn.1006-298X.2018.02.003

• Article • Previous Articles     Next Articles

Antiglomerular basement membrane disease combined with IgA nephropathy or membranous nephropathy

  

  • Online:2018-04-28 Published:2018-05-02

Abstract:

Objective:To investigated the differences in clinical characteristics,pathological features and prognosis of antiglomerular basement membrane (GBM) disease combined with IgA nephropathy or membranous nephropathy.
Methodology:From January 2004 to December 2015, seventy five patients with antiGBM disease were enrolled into this retrospective study. According to the pathological diagnosis, the patients were divided into three group, including 10 cases of antiGBM disease with IgA nephropathy (with IgAN group), 5 cases of antiGBM disease with membranous nephropathy (with MN group) and 60 cases of simple antiGBM disease (simple antiGBM disease group). The clinical, laboratory and pathological indices were compared among the three groups.
Results:In patients of antiGBM disease with IgAN group and with MN group, they had lower percents of anuria, while more urine protein and microscope hematuria, and a lower level of antiGBM antibodies, but not statistical significance. Furthermore, the patients in simple antiGBM disease group were more serious in renal dysfunctions, which represented as highest percents of rapidly progressive glomerulonephritis (RPGN) (P=0004), highest levels of hypertension (P=0002), serum creatinine (SCr,P<0001) and a more serious degree of anemia (P<0001). In pathology, the patients in simple antiGBM disease group were observed to have the highest percentage of crescents in glomeruli (P=0008) and Bowmans wall fracture (P=0005). In the course of treatment, the patients in simple antiGBM disease group had the highest proportion of continuous renal replacement therapy(P=0008). During the followup, the patients in simple antiGBM disease group had the highest percentage of end stage renal disease (ESRD) in one years (P<0001).
Conclusion:
AntiGBM disease with IgA nephropathy or membranous nephropathy is different from simple antiGBM disease in clinical manifestations, laboratory indices, pathology and prognosis.

Key words: anti-glomerular basement membrane disease, IgA nephropathy, membranous nephropathy, crescentic glomerulonephritis